Biotech · Private company
Array BioPharma
Track this companyFree. Adds Array BioPharma to your Dealase workspace and tells you when its record changes.
Clinical trials143 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials14
- Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant MelanomaPHASE2 · RECRUITING · started Mar 3, 2021ClinicalTrials.gov NCT04598009 · fetched Nov 12, 2026
- Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype MelanomaPHASE2 · TERMINATED · started Dec 3, 2020ClinicalTrials.gov NCT04375527 · fetched Nov 12, 2026
- Study of ARRY-614 Plus Either Nivolumab or Nivolumab+IpilimumabPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 11, 2020ClinicalTrials.gov NCT04074967 · fetched Nov 12, 2026
- Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung CancerPHASE1 · TERMINATED · started Feb 25, 2020ClinicalTrials.gov NCT04005144 · fetched Nov 12, 2026
- Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 8, 2019ClinicalTrials.gov NCT03971409 · fetched Nov 12, 2026
- A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant CancersPHASE1_PHASE2 · COMPLETED · started Feb 14, 2019ClinicalTrials.gov NCT03843775 · fetched Nov 12, 2026
- Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)PHASE1 · COMPLETED · started Feb 16, 2018ClinicalTrials.gov NCT03374254 · fetched Nov 12, 2026
- Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform NeurofibromasPHASE2 · COMPLETED · started Nov 28, 2017ClinicalTrials.gov NCT03231306 · fetched Nov 12, 2026
- Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung CancerPHASE1 · COMPLETED · started May 31, 2017ClinicalTrials.gov NCT03170206 · fetched Nov 12, 2026
- MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal CancerPHASE1 · COMPLETED · started Jul 16, 2014ClinicalTrials.gov NCT02041481 · fetched Nov 12, 2026
- A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR MutationPHASE1 · COMPLETED · started Dec 30, 2013ClinicalTrials.gov NCT01859026 · fetched Nov 12, 2026
- ARRY-380 + Trastuzuamab for Breast w/ Brain MetsPHASE1 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01921335 · fetched Nov 12, 2026
- BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 MutationPHASE2 · COMPLETED · started Jul 1, 2013ClinicalTrials.gov NCT01894672 · fetched Nov 12, 2026
- A Study of ARRY-380 in Patients With Advanced HER2+ CancerPHASE1 · COMPLETED · started May 1, 2008ClinicalTrials.gov NCT00650572 · fetched Nov 12, 2026